2 links tagged with all of: healthcare + drug-development
Click any tag below to further narrow down your results
Links
Clara Collier interviews Abhishaike Mahajan from Noetik about the role of AI in developing cancer treatments. Mahajan shares his experience in machine learning applications across health insurance and genetic therapies, focusing on using AI to better understand tumor microenvironments and improve drug response predictions.
The FDA plans to reduce the number of required pivotal trials in Phase 3 clinical studies from two to one, aiming to streamline drug development. While this may benefit smaller biotech companies, the impact will vary by disease, as some conditions may still necessitate more trials to ensure safety and efficacy.